Core Viewpoint - China Xuyang Group (01907) announced the termination of a framework agreement with Beijing Yihuatong regarding potential sale and capital increase due to the inability to reach a final agreement [1] Group 1 - The parties involved have mutually agreed to terminate the framework agreement and have released each other from their respective obligations under the agreement [1] - A termination agreement was signed on September 5, 2025, which will take effect immediately [1] - The board of directors believes that the termination of the framework agreement will not have any significant adverse impact on the company's business operations and financial condition [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負 責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或 任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 China Risun Group Limited 中國旭陽集團有限公司 （於開曼群島註冊成立的有限公司） （股份代號：1907） 本集團將繼續尋求與北京億華通的任何潛在戰略合作機會，並將根據上市規則適 時刊發進一步公告。 承董事會命 中國旭陽集團有限公司 主席 楊雪崗 香港，2025年9月5日 於本公告日期，執行董事為楊雪崗先生、路小梅女士、李慶華先生、韓勤亮先 生、王年平先生及楊路先生；及獨立非執行董事為余國權博士、王引平先生及劉 曉峰博士。 終止有關潛在出售事項及潛在增資的框架協議 茲提述中國旭陽集團有限公司（「本公司」）日期為2025年3月12日的公告（「該公 告」），內容有關旭陽集團與北京億華通訂立的框架協議項下的潛在出售事項及潛 在增資。除另有說明外，本公告所用詞彙與該公告所界定者具相同涵義。 董事會謹此宣佈，由於交易雙方未能就本次潛在出售事項及潛在增資的最終方案 達成一致意見，為切實維護本公 ...

Core Viewpoint - The report highlights that Xuyang Group is successfully navigating through an industry adjustment period while achieving resilient growth and business integration, marking a critical transition point as it approaches its seventh five-year development plan for 2026-2030 [1][2]. Financial Performance - In the first half of 2025, Xuyang Group reported a revenue of 20.549 billion yuan, with a gross profit of 1.686 billion yuan, resulting in a gross margin of 8.2% and a net profit of 86.908 million yuan [3]. - The fine chemicals segment generated a revenue of 9.096 billion yuan, accounting for 44.3% of total revenue, while the coke and coking segment reported a revenue of 6.358 billion yuan [3]. Business Segments Growth - The fine chemicals segment experienced a business volume of 2.9 million tons, up 11.5% year-on-year, while the coke segment's business volume reached 10.9 million tons, increasing by 25.3% [1]. - The hydrogen energy segment reported a business volume of 1.11 million cubic meters, reflecting a year-on-year growth of 16.8% [1]. Strategic Initiatives - Xuyang Group successfully acquired a controlling stake in Yihua Tong, marking the largest transaction in the hydrogen energy sector in recent years, and is progressing towards building a hydrogen energy ecosystem worth 10 billion yuan [1]. - The company has established a presence in Brazil and is preparing to set up trading offices in Europe, expanding its international footprint with 11 subsidiaries or offices across 41 countries and regions [2]. Future Outlook - The company is set to launch its seventh five-year development plan in 2026, with a clear path for future growth driven by acquisitions, external collaborations, and global market expansion [2][7]. - Upcoming projects include a 50,000-ton/year high-end polyamide new materials project expected to commence production in October 2025, alongside ongoing research into high-value fine chemical products [7]. Hydrogen Energy Development - Xuyang Group is actively involved in hydrogen industrialization projects in various regions and has completed the necessary licensing for hazardous chemicals, enhancing its competitive edge [4]. - The company is developing a 5-ton/day liquid hydrogen demonstration project, which is expected to be completed next year, positioning it as a leader in the domestic liquid hydrogen market [4][9]. Innovation and Product Development - The company has successfully built and put into operation the first domestic industrial-scale amino alcohol production facility, becoming the second company globally to produce amino alcohols industrially [5]. - The amino alcohols produced are widely applicable in various industries, with prices ranging from 60 to 150 yuan per kilogram based on purity, indicating high added value [5][6].

Group 1 - The company announced a share award plan adopted at the annual general meeting held on May 30, 2025 [1] - A total of 9.915 million shares will be granted to 197 eligible participants, including directors and employees of the group [1] - The grant of shares is subject to acceptance by the participants [1]

Core Viewpoint - China Xuyang Group (01907) announced a mid-term dividend of 0.002 yuan per share to be distributed on September 30, 2025 [1] Company Summary - The company is set to distribute a mid-term dividend, indicating a commitment to returning value to shareholders [1]

Group 1 - The core point of the article is that China Xuyang Group has announced a share award plan to grant a total of 9.915 million shares to 197 eligible participants, including directors and employees, as part of its strategy to attract, retain, and incentivize talent [1] - The share award plan was adopted during the company's annual general meeting held on May 30, 2025 [1] - The purpose of granting these shares is to encourage participants to enhance the value of the company and its shares for the benefit of the company and its shareholders [1]

Core Viewpoint - China Xuyang Group (01907) announced a share award plan to grant a total of 9.915 million shares to 197 eligible participants, including directors and employees, pending acceptance by the participants [1] Group 1 - The share award plan was adopted during the company's annual general meeting held on May 30, 2025 [1] - The shares will be granted on September 1, 2025, subject to acceptance by the participants [1]

Group 1 - The company, China Xuyang Group (01907), announced a mid-term dividend of 0.002 yuan per share to be distributed on September 30, 2025 [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴 該等內容而引致的任何損失承擔任何責任。 China Risun Group Limited 中國旭陽集團有限公司 （於開曼群島註冊成立的有限公司） （股份代號：1907） 授出股份獎勵 承授人： (i) 李慶華先生，本公司執行董事兼執行總裁； (iv) 本集團194名僱員。 1 (ii) 韓勤亮先生，本公司執行董事兼高級副總裁； (iii) 王年平先生，本公司執行董事兼高級副總裁；及 本公告乃根據香港聯合交易所有限公司證券上市規則（「上市規則」）第17.06A、 17.06B及17.06C條的規定而作出。 中國旭陽集團有限公司（「本公司」，連同其附屬公司統稱為「本集團」）董事（「董 事」）會（「董事會」）宣佈，本公司於2025年9月1日根據本公司於2025年5月30日舉 行的股東週年大會上採納的股份獎勵計劃（「股份獎勵計劃」）向本公司197名合資 格參與者（「承授人」）（包括董事及本集團僱員）授出合共9,915,000股本公司股份 （「股份」） ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 致：香港交易及結算所有限公司 公司名稱: 中國旭陽集團有限公司 呈交日期: 2025年9月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01907 | 說明 | 股份 | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | 10,000,000,000 | | HKD | | 0.1 HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 10,000,000,000 | HKD | | 0.1 HKD | | 1,000,000,000 | 本月底法定/註冊股本總額： HKD 1,000,000,000 FF301 截至 ...